Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Melanoma 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 19pembrolizumab 14Surveys and Questionnaires 7Radiotherapy 7Paclitaxel 7Magnetic Resonance Spectroscopy 7Gemcitabine 7Standard of Care 6Specimen Handling 6Radiosurgery 6Psychiatric Rehabilitation 6Early Intervention, Educational 6Trastuzumab 5Nivolumab 5enzalutamide 4Interviews as Topic 4motexafin gadolinium 3cabozantinib 3X-Rays 3Sirolimus 3Methods 3Educational Status 3Cisplatin 3Carboplatin 3Azacitidine 3tisotumab vedotin 2rucaparib 2pertuzumab 2pegilodecakin 2palbociclib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × SGN-LIV1A × Thoracic × Clear all
NCT04032704 2025-03-10

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

Seagen Inc.

Phase 2 Terminated
205 enrolled 54 charts
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡